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Abstract
Background:  The recruitment of lymphocytes to secondary lymphoid organs relies on
interactions of circulating cells with high endothelial venules (HEV). HEV are exclusive to these
organs under physiological conditions, but they can develop in chronically-inflamed tissues. The
interaction of L-selectin on lymphocytes with sulfated glycoprotein ligands on HEV results in
lymphocyte rolling, which represents the initial step in lymphocyte homing. HEV expression of
GlcNAc6ST-2 (also known as HEC-GlcNAc6ST, GST-3,  LSST or CHST4), an HEV-restri cted
sulfotransferase, is essential for the elaboration of L-selectin functional ligands as well as a critical
epitope recognized by MECA-79 mAb.
Results: We examined the expression of GlcNAc6ST-2 in relationship to the MECA-79 epitope
in rheumatoid arthritis (RA) synovial vessels. Expression of GlcNAc6ST-2 was specific to RA
synovial tissues as compared to osteoarthritis synovial tissues and localized to endothelial cells of
HEV-like vessels and small flat-walled vessels. Double MECA-79 and GlcNAc6ST-2 staining showed
colocalization of the MECA-79 epitope and GlcNAc6ST-2. We further found that both TNF-α  and
lymphotoxin-αβ  induced GlcNAc6ST-2  mRNA and protein in cultured human umbilical vein
endothelial cells.
Conclusion: These observations demonstrate that GlcNAc6ST-2 is induced in RA vessels and
provide potential cytokine pathways for its induction. GlcNAc6ST-2 is a novel marker of activated
vessels within RA ectopic lymphoid aggregates. This enzyme represents a potential therapeutic
target for RA.
Background
Rheumatoid arthritis (RA) is an autoimmune disease
characterized by chronic inflammation of the synovial
membrane that leads to the destruction of cartilage and
bone tissues. The major cellular components of the
inflammatory infiltrate in RA synovium are T cells, macro-
phages, B cells, and dendritic cells (DCs) [1]. Tissue-infil-
trating lymphocytes are often arranged in follicles which
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exhibit variable degrees of germinal center (GC) reactions
[2-4]. These highly organized structures are similar to sec-
ondary lymphoid organs, and the process is referred to as
lymphoid neogenesis [5,6]. In RA, this ectopic formation
of lymphoid structures correlates with the expression of
lymphotoxin-β  (LT-β ) and homing chemokines such as
BLC (CXCL13) and SLC (CCL21), recapitulating the
developmental process of lymphoid organogenesis [7].
The recruitment of cellular elements to secondary lym-
phoid organs relies on interactions between circulating
leukocytes and the specialized endothelium of high
endothelial venules (HEV), which are exclusive to these
organs under physiological conditions. The interaction of
L-selectin on lymphocytes with sulfated glycoprotein lig-
ands on HEV of lymph nodes results in lymphocyte roll-
ing on endothelium which represents the initial step in
lymphocyte homing [8]. HEV-ligands for L-selectin con-
sist of a set of heavily O-glycosylated glycoproteins, which
include GlyCAM-1 and CD34 in the mouse and podoca-
lyxin and CD34 in the human [9]. Recognition of these
ligands by L-selectin requires sialylation, fucosylation and
sulfation of their mucin-like domains [10]. The minimal
recognition epitope appears to be comprised of a capping
group known as 6-sulfo sialyl Lewis x (6-sulfo sLex) in
which the C-6 position of GlcNAc is esterified with sul-
fate. The MECA-79 mAb recognises a critical sulfation-
dependent determinant on these ligands that overlaps
with the L-selectin recognition epitope. Expression of
GlcNAc6ST-2 (commonly referred to as HEC-GlcNAc6ST
or LSST), an HEV-localized sulfotransferase, is essential
for the elaboration of functional ligands within lymph
nodes, as well as the generation of the MECA-79 epitope
[11-13]. Another sulfotransferase known as GlcNAc6ST-1
also contributes to this epitope in HEV [14]. MECA-79
recognizes a set of sialomucins, including the aforemen-
tioned L-selectin ligands, together with another recently
identified sialomucin called endomucin [15,16]. The
complex is referred to as peripheral node addressin
(PNAd) [13]. MECA-79 blocks the attachment of lym-
phocytes to peripheral lymph node (PN) HEV in vitro and
inhibits lymphocyte homing to PN in vivo [17].
The role of GlcNAc6ST-2 in the generation of L-selectin
ligands in lymphoid organs has been clearly established
in mice genetically deficient in this enzyme [18-20]. Lym-
phocyte homing to PN is reduced in the GlcNAc6ST-2 -/-
mice as reflected by a smaller size of the PN and a 60%
decrease in the number of total lymphocytes within this
organ. In addition to lymphoid organs, induction of the
MECA-79 epitope has been identified in several chroni-
cally inflamed tissues where it is proposed to participate
in leukocyte recruitment [21]. Inflamed synovium con-
tains high-walled vessels, resembling HEV, which express
the MECA-79 epitope and are capable of binding L-selec-
tin+ lymphocytes in ex vivo assays [21-25].
Recently, the use of GlcNAc6ST-2 specific antibodies has
demonstrated de novo induction of this enzyme in HEV-
like vessels and its correlation with the presence of the
MECA-79 epitope in several mouse models of chronic
inflammation [26]. In this study using an antibody to
human GlcNAc6ST-2, we analyse whether this enzyme is
expressed in RA and in cultured endothelial cells and its
correlation with the expression of MECA-79 epitope.
Results
Expression of MECA-79 epitope and GlcNAc6ST-2 in 
synovial tissues
We produced an anti-human GlcNAc6ST-2 antibody and
tested it on human lymph node and tonsil sections. A vas-
cular pattern of labelling was observed which colocalized
to MECA-79 positive vessels of HEV morphology (Figure
1a). A few mononuclear cells were also labelled with the
anti GlcNAc6ST-2 antibody. Expression of the MECA-79
epitope was detected in 7 of 14 RA and none of the 9 OA
synovial tissues. Most MECA-79+ vessels showed a HEV
morphology but in some cases, small vessels with a flat
endothelium were also labelled. Five of the 7 MECA-79+
tissues contained abundant lymphocytic infiltrates, which
in 4 cases displayed a follicular pattern, and in 2 cases,
MECA-79+ vessels were observed in the absence of signifi-
cant infiltration (Table 1). Three MECA-79 negative RA
tissues contained diffuse lymphocytic infiltrates and in
one case, a single follicular infiltrate.
Expression of GlcNAc6ST-2 was not detected in any of the
OA synovial tissues. In contrast, 10 of 14 RA tissues
showed GlcNAc6ST-2 by immunoperoxidase staining
(Figure 2). Staining was located to endothelial cells of
HEV vessels in the sublining and in some samples, also in
small vessels with flat endothelium. In some sections, a
few perivascular mononuclear cells were also stained.
Double MECA-79 and GlcNAc6ST-2 immunofluores-
cence showed that all MECA-79 positive vessels also dis-
played GlcNAc6ST-2 (Figure 1b). However, in a low
proportion of GlcNAc6ST-2+ vessels, MECA-79 was not
detected.
Specificity of the immunoperoxidase GlcNAc6ST-2 label-
ling was confirmed by substituting normal rabbit IgG for
the specific antibody. There was no detectable staining
(data not shown). Preincubation of the anti-GlcNAc6ST-2
antibody with the peptide immunogen abrogated the
staining (Figure 2b). We also immunostained with a pol-
yclonal antibody raised against murine GlcNAc6ST-2 [26]
and observed a similar pattern of staining in small vessels
(Figure 2c). This antibody reacted with smooth muscle
cells in the media of larger vessels which we attribute to aBMC Immunology 2005, 6:6 http://www.biomedcentral.com/1471-2172/6/6
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spurious cross-reactivity (data not shown). Immunostain-
ing with this antibody was also abrogated by preincuba-
tion with murine GlcNAc6ST-2 peptide (Figure 2d).
Expression of GlcNAc6ST-2 by cultured HUVEC
To analyze the potential role of LT-αβ  and TNF-α , two
cytokines abundantly expressed in RA synovium and
Double immunofluorescent detection of the MECA-79 epitope and GlcNAc6ST-2 in human lymph node and RA synovial  tissues Figure 1
Double immunofluorescent detection of the MECA-79 epitope and GlcNAc6ST-2 in human lymph node and 
RA synovial tissues. Sections were simultaneously labelled with MECA-79 (red) and anti-GlcNAc6ST-2 (green) antibodies 
and photographed under appropriate filters. On the right panels, a merged image shows colocalization of both markers (yel-
low). (a) Lymph node. (b) RA synovium; Two MECA-79 negative and GlcNAc6ST-2 positive vessels are marked by arrows. 
Original magnification (a) 200×. (b) 150×. Selected areas within squared insets are shown on the lower right corner insets with 
higher magnification (630×).
Table 1: Summary of immmunodetection of the MECA-79 epitope and GlcNAc6ST-2 in RA tissues.
Tissues Lymphocytic infiltration MECA-79 GlcNAc6ST-2
RA1 Follicular + +
RA2 Follicular + +
RA3 Follicular + +
RA4 Follicular + +
RA5 Diffuse + +
RA6 Negative + +
RA7 Negative + +
RA8 Follicular - +
RA9 Diffuse - +
RA10 Negative - +
RA11 Diffuse - -
RA12 Negative - -
RA13 Negative - -
RA14 Negative - -
MECA-79 HEC-GST Merged
a
bBMC Immunology 2005, 6:6 http://www.biomedcentral.com/1471-2172/6/6
Page 4 of 9
(page number not for citation purposes)
Immunoperoxidase staining of RA and OA synovial tissue with anti-GlcNAc6ST-2 antibodies Figure 2
Immunoperoxidase staining of RA and OA synovial tissue with anti-GlcNAc6ST-2 antibodies. RA (a-d) or OA (e, 
f) synovial tissue sections were immunostained with anti-human GlcNAc6ST-2 (a, b, e) or anti-mouse GlcNAc6ST-2 (c, d, f) 
antibody. Color was developed with DAB peroxidase substrate (brown color) and sections were counterstained with hema-
toxylin. Sections b and d are serial to a and c respectively, and were preincubated with human or mouse GlcNAc6ST-2 peptide 
to demonstrate the specificity of immunostaining. Original magnification: 400×.
ab
cd
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associated with lymphoid neogenesis and GlcNAc6ST-2
expression in transgenic models [3-7,26,28], we examined
the effects of the exposure to these cytokines on
GlcNAc6ST-2 expression in human endothelial cells lack-
ing the HEC phenotype (HUVEC).
By RT-PCR, treatment with LT-αβ  or TNF-α  for 8 h
induced a significant increase in the expression of
GlcNAc6ST-2 mRNA in HUVEC (Figure 3a). A synergistic
effect of treatment with both cytokines was not detected
(data not shown). Treatment with an unrelated cytokine
(interferon-γ ) did not significantly modify GlcNAc6ST-2
mRNA expression levels.
By western blot analysis with the anti-human GlcNAc6ST-
2 antibody, we detected a single 50 kD band in HUVEC
protein extracts, consistent with the expected MW for
human GlcNAc6ST-2 [11,12]. GlcNAc6ST-2 protein
expression was significantly increased after 24 h of TNF-α
or LT-αβ  treatment in HUVEC (Figure 3b). Immunofluo-
rescent labelling of HUVEC cultures with anti-human
GlcNAc6ST-2 antibody showed a weak, but clearly detect-
able signal above the non-immune rabbit IgG control.
Pretreatment with either TNF-α  or LT-αβ  induced a clear
increase of immunofluorescence with a perinuclear distri-
bution which is characteristic of the Golgi apparatus (Fig-
ure 3c). Neither TNF-α  nor LT-αβ  treatment induced
expression of the MECA-79 epitope in HUVEC (data not
shown).
Discussion
The presence of MECA-79+ vessels has been previously
reported in human inflammatory lesions, often associated
with the development of lymphoid neogenesis [21,26]. In
a variety of unrelated inflammatory conditions (rejecting
heart and kidney allografts, peribronchial specimens from
asthmatics, thyroiditis, psoriasis, and H. pylori infection)
induction of MECA-79+ vessels in association with inflam-
matory infiltrates has been demonstrated [29,32]. In
some cases, MECA-79+ vessels also display HEV-like mor-
phology although flat endothelium of inflammatory ves-
sels can also express the MECA-79 epitope. In chronic
arthritis synovial tissues, the presence of HEV and MECA-
79+ vessels has been previously demonstrated [22,23].
Recently, the pathophysiological significance of MECA-
79+ vessels has been directly demonstrated in a sheep
model of asthma. Pretreatment of asthmatic sheep with
intravenously administered MECA-79 blunted both late-
phase airway responses and airway hyperresponsiveness
induced by airway allergen challenge [33].
In murine models of lymphoid neogenesis, including
spontaneous models (AKR mouse and NOD mouse), and
transgenic models (RIP-BLC and RIP-LT-αβ ), expression
of the MECA-79 epitope is closely associated with the
induction of GlcNAc6ST-2 [12,26,28]. Taking advantage
of a newly-generated antibody to human GlcNAc6ST-2,
our present results are the first to show this association in
a chronic inflammatory disease in humans. Several of our
observations suggest that the induction of GlcNAc6ST-2
represents an early event in the process of lymphoid neo-
genesis within RA synovium. In the first place,
GlcNAc6ST-2 was expressed in flat and high endothelial
vessels which exceeded the number of MECA-79+ vessels
in double-labelled sections. Secondly, GlcNAc6ST-2 and
MECA-79 reactivity were detected in some vessels which
were not associated with lymphoid aggregates, and in a
few cases, even in the absence of significant mononuclear
cell infiltration. The latter observation also suggests that
MECA-79+ vessels may contribute to lymphoid recruit-
ment, but additional factors are necessary. This is consist-
ent with the multistep model of leukocyte
transendothelial migration to lymphoid organs, where
posting of chemokines on endothelium and integrin-
mediated adhesion of rolling leukocytes are required [8].
Lack of expression of MECA-79 epitope and GlcNAc6ST-2
in OA samples suggests that the scanty infiltration of OA
tissues is not sufficient to induce these features and that
RA-associated factors are needed.
The development of lymphoid neogenesis in RA syn-
ovium has been suggested to facilitate local autoimmune
responses permitting the development of B cells and local
production of autoantibodies and immune complex for-
mation [34-36]. The recent development of B-cell deplet-
ing therapy demonstrates an important role for these cells
in RA [37]]. The recruitment of L-selectin+ dendritic cells,
B-cells and CD45RA T-cells to RA synovium correlates
with the expression of homing chemokines such as
CXCL13, CCL19 and CCL21, and the latter partially colo-
calizes to MECA-79 positive HEV [3,38,39]. We have also
detected expression of CXCL12, a homing chemokine
abundantly present in RA tissues in HEV-like vessels [40].
Local expression of LT-β  and TNF-α  are important factors
in the pathogenesis of RA, and LT-β  expression correlates
with the expression of homing chemokines and lymphoid
neogenesis [1,3]. The role of LT-αβ  and homing chemok-
ines in the induction of HEV has been suggested by
murine studies in RIP-LT-αβ  and RIP-BLC (CXCL13) mice
which spontaneously develop lymphoid aggregates and
GlcNAc6ST-2 expression in MECA-79+ vessels [26,28,29].
The role of this enzyme in lymphoid recruitment has also
been studied in RIP-BLC/ GlcNAc6ST-2-/- mice which
exhibit a reduction in lymphoid infiltration [26].
We demonstrate that de novo induction of GlcNAc6ST-2
expression also occurs upon LT-αβ  or TNF-α  stimulation
in cultured HUVEC, further supporting the role of LT-αβ
and TNF-α  as major inducers of extranodalBMC Immunology 2005, 6:6 http://www.biomedcentral.com/1471-2172/6/6
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Expression of GlcNAc6ST-2 in cultured HUVEC Figure 3
Expression of GlcNAc6ST-2 in cultured HUVEC. (a) Real time RT-PCR quantification of GlcNAc6ST-2 mRNA in cultured 
HUVEC. HUVEC cultures were stimulated for 8 h with LT-αβ  (LT), TNF-α  (TNF), or interferon-γ  (IFN) and mRNA obtained 
from stimulated and non-stimulated cells. Basal (non-stimulated) expression was set to 1 and the GlcNAc6ST-2/β -actin ratio in 
stimulated cells is shown (mean ± SD of three independent experiments, each including triplicate HUVEC cultures). (*) p < 
0.05. (b) Western blot analysis of GlcNAc6ST-2 in cultured HUVEC stimulated for 24 h with LT-αβ  (LT) or TNF-α  (TNF), 
(data are representative of three independent experiments with different HUVEC lines).(c) Immunofluorescent detection of 
GlcNAc6ST-2 protein in cultured HUVEC endothelial cells non-stimulated (Basal) or stimulated for 24 h with LT-αβ  (LT) or 
TNF-α  (TNF). In control (CTRL) panel, anti-GlcNAc6ST-2 antibody was replaced by non-immune rabbit IgG (images are rep-
resentative of three independent experiments).
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lymphogenesis. Enforced LT-αβ  expression in murine
models of lymphoid neogenesis induces the expression of
homing chemokines, making it difficult to dissect the role
of LT-αβ  and chemokines in GlcNAc6ST-2 expression and
HEV-development [41]. A role for LT-αβ , which is down-
stream of chemokines, has been observed in a transgenic
model of BLC expression by genetic or functional target-
ing of LT-αβ  [42]. In murine models of extranodal lym-
phoid neogenesis, a non redundant role for LT-αβ
signaling through the alternative NF-κ B pathway has been
demonstrated, whereas the role for TNF-α  seems dispen-
sable and ectopic LT-α  does not induce GlcNAc6ST-2
expression (13, 28). Our data suggest that in human cul-
tured EC TNF-α  may contribute to this process by induc-
ing GlcNAc6ST-2 although its relevance in vivo remains to
be determined. Therefore, our data suggest that both LT-
αβ  and TNF-α  can directly induce GlcNAc6ST-2 in cul-
tured endothelial cells, although additional factors seem
to be required for the full development of the HEC phe-
notype in vitro. One such factor may be the core 1 exten-
sion enzyme, known as Core1-β  3GlcNAcT, which is
required for the formation of the MECA-79 epitope on O-
glycans [29,43]. Our results further establish carbohydrate
modifying enzymes as an important group of transcrip-
tional targets for cytokines during inflammation.
Increased carbohydrate sulfation of several glycoproteins,
including heparan sulfate proteoglycans, CD44 and air-
way mucins, has previously been demonstrated in
response to TNF-α  [44-46].
In RA, TNF-α  plays a major and multifunctional role in
the pathogenesis of the disease whereas the role of LT-αβ
is currently being explored [47]. The potential contribu-
tion of these factors to the development of HEV expands
the spectrum of possible pathogenetic roles for these
cytokines.
Conclusion
MECA-79 defined glycoproteins serve as ligands for L-
selectin during the process of lymphocyte homing to
lymph nodes. This class of ligands is also critical for
inflammatory leukocyte trafficking and the associated dis-
ease, as recently demonstrated in a sheep model of
asthma. Previous experiments in the mouse have shown
the requirement for GlcNAc6ST-2 in generating the
MECA-79 epitope and the associated L-selectin ligand
activity in HEV and HEV-like vessels. Here, we demon-
strate that MECA-79+ vessels within human RA synovium
also express GlcNAc6ST-2, strongly implying that this
enzyme contributes to the ligands on these vessels. Estab-
lishing the direct participation of GlcNAc6ST-2 in the for-
mation of L-selectin ligands on RA HEV would identify
this enzyme as a potential therapeutic target for inhibiting
leukocyte recruitment to the joints. In the same context,
our finding that TNF-α  induces GlcNAc6ST-2 in cultured
endothelial cells may help to rationalize the efficacy of
anti TNF-α  therapy in the treatment of RA and other
inflammatory diseases. Moreover, the activity of LT-αβ  in
inducing GlcNAc6ST-2 in HUVEC is likely related to the
established requirement for this cytokine in the formation
of HEV during lymphoid organ development. Many
opportunities for future investigation are clearly
indicated.
Methods
Preparation of anti-human GlcNAc6ST-2 antibody
A polyclonal antibody against human GlcNAc6ST-2 was
prepared following the same basic procedures used for
mouse GlcNAc6ST-2 [26]. The peptide chosen, RGKGM-
GDHAFHTNC, differed from that of the corresponding
mouse sequence by one amino acid (D replacing Q) with
the C-terminal C added to facilitate conjugation. The pep-
tide was coupled to KLH and injected into New Zealand
White rabbits by Covance Research Products (Denver,
PA). 500 µg of conjugated peptide was mixed with 0.5 ml
complete Freund's adjuvant and injected intradermally,
followed by three boosts, every three weeks, with subcuta-
neous injections of 250 µg conjugated peptide in 0.5 ml
incomplete Freund's adjuvant. The subsequent antiserum
was subjected to purification on the immunogen peptide
coupled to agarose using the SulfoLink Kit (Pierce Bio-
technology, Rockford, IL), following the manufacturer's
recommendations. The affinity purified antibody was
washed into Dulbecco's PBS on a Centricon 30 (Millipore,
Billerica, MA) and concentrated to 0.125 mg/ml.
GlcNAc6ST-2 and MECA-79 immunolabeling
Synovial tissues were obtained from 14 RA and 9 control
(OA) patients at the time of knee prosthetic replacement
surgery. All patients gave informed consent, and the study
was approved by the ethics committee of the Hospital 12
de Octubre.
Tissues were snap frozen in OCT and stored at -80°C.
Human tonsil and lymph nodes frozen sections were used
as controls for MECA-79 and GlcNAc6ST-2
immunolabeling.
Frozen sections (8 µm) were fixed for 10 minutes in cold
acetone. Double GlcNAc6ST-2 and MECA-79 immunola-
beling was performed by blocking for 30 minutes in 5%
normal goat serum PBS, followed by incubation of sec-
tions with 1.4 µg/ml MECA-79 mAb (rat IgM) and 0.3 µg/
ml rabbit anti-human GlcNAc6ST-2 at room temperature
for 1 hour. After washing in PBS, a secondary biotinylated
goat anti-rabbit IgG at 1.3 µg/ml was added (Jackson
Immunoresearch Laboratories, West Grove, PA). Fluores-
cence was developed with 1.5 µg/ml Cy3-conjugated goat
anti-rat IgM and 1.8 µg/ml Cy2-conjugated streptavidin
(Jackson Immunoresearch Laboratories).BMC Immunology 2005, 6:6 http://www.biomedcentral.com/1471-2172/6/6
Page 8 of 9
(page number not for citation purposes)
Immunoperoxidase staining was performed by overnight
incubation at 4°C with either anti-human or anti-mouse
GlcNAc6ST-2. Endogenous peroxidase was blocked in 0.3
% H2O2 in methanol. Immunoperoxidase detection was
performed by ABC method according to the manufacturer
(Vectastain®, Vector Laboratories, Burlingame, CA). Perox-
idase activity was developed by diaminobenzidine sub-
strate and slides were counterstained in Gills
hematoxylin. Controls with non-immune rabbit IgG at
the same concentration as anti-human or anti-mouse
GlcNAc6ST-2 antibodies were included. Additional con-
trols were performed by preincubating sections with
human or mouse GlcNAc6ST-2 peptide at 10 µg/ml. To
ensure identical conditions, RA and OA sections were
mounted on the same slide and all slides were processed
in parallel.
GlcNAc6ST-2 expression in HUVEC cultures
Human umbilical vein endothelial cells (HUVEC) were
prepared from umbilical cords by collagenase digestion
and were propagated in medium 199 (Life Technologies,
Paisley, Scotland) with 20% FCS. Cultured cells were char-
acterized as EC by flow cytometry with anti-endothelial
cell antibody P1H12 (Chemicon International, Temecula,
CA). The presence of HEC in these cultures was excluded
by flow cytometry with MECA-79 mAb.
HUVEC cultures were stimulated with either 25 ng/ml of
TNF-α , 20 ng/ml of LT-α 1/β 2, or 200 ng/ml of interferon-
γ  (R&D Systems, Inc., Abingdon, UK) for 8–24 h and total
RNA or protein were extracted. For immunofluorescent
detection of GlcNAc6ST-2, HUVEC were cultured on glass
coverslips and similarly treated. Coverslips were fixed
with 4% paraformaldehyde and immunofluorescent
detection of GlcNAc6ST-2 was performed as described
above for tissue sections.
RT-PCR was performed on cDNA synthesized from 1 µg of
total RNA of EC cultures using the following GlcNAc6ST-
2  oligonucleotides: upstream 5'-GCAGCATGAGCA
AAAACTCAAG-3' and downstream 5'-TCCAGGTAGACA-
GAAGATCCAG-3', and β -actin oligonucleotides upstream
5'-CTACCTCATGAAGATCCTCAC-3' and downstream 5'-
GTCCACGTCACACTTCATGATG-3'. Real-time monitor-
ing of PCR reactions was performed on a Roche LightCy-
cler instrument, using SYBR Green I kit (Roche
Diagnostics, Mannheim, Germany). The specificity of the
amplicons was checked by electrophoresis which demon-
strated single transcripts of 449 bp (GlcNAc6ST-2) and
303 bp (β -actin) as expected. For relative quantification,
we calculated the n-fold differential expression by the ∆ Ct
method (Ct denoting the threshold cycle of PCR amplifi-
cation at which product is first detected by fluorescence)
that compares the amount of target gene amplification,
normalized to the β -actin endogenous reference as previ-
ously described [27].
Western blot detection of GlcNAc6ST-2 was performed on
HUVEC protein extracts (50 µg) electrophoresed on a
10% polyacrylamide gel and electrophoretically trans-
ferred to nitrocellulose filters. Membranes were incubated
overnight with either rabbit anti-human GlcNAc6ST-2 or
control anti-β  actin (clone AC-15, Sigma-Aldrich
Química, Spain) antibodies in 5% non-fat dried milk-
TBST. The filters were washed and incubated for 1 h with
secondary antibodies linked to peroxidase at 0.08 µg/ml
(Santa Cruz Biotechnology, Santa Cruz, CA). Bands were
visualized by an enhanced chemiluminiscence system
(Pierce, Rockford, IL).
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